This was a retrospective observational cohort study of 324 postmenopausal female patients with type 2 diabetes mellitus hospitalized at a single center from September 2021 to November 2024. The study evaluated the Geriatric Nutritional Risk Index (GNRI) as an exposure, comparing patients to a non-osteoporosis group defined by a T-score greater than −2.5.
The primary outcome was the presence of postmenopausal osteoporosis (PMOP). The main result indicated that a higher GNRI value was independently associated with a lower risk of PMOP. The secondary outcome showed that the GNRI demonstrated moderate discriminatory ability for PMOP. No specific effect sizes, absolute numbers, p-values, or confidence intervals were reported for these associations.
Safety and tolerability were not reported; no adverse events, serious adverse events, or discontinuations were documented. Key limitations include the retrospective design, single-center setting, and the need for further prospective validation. The study authors note the findings represent an association, not causation.
The practice relevance suggests the GNRI may serve as a simple auxiliary indicator for assessing skeletal health risk in clinical practice. However, the certainty is limited by the observational design, and findings require further prospective validation before broader application.
View Original Abstract ↓
To investigate the association between the Geriatric Nutritional Risk Index (GNRI) and the presence of postmenopausal osteoporosis (PMOP) in elderly female patients with type 2 diabetes mellitus (T2DM), and to evaluate the discriminatory ability of GNRI for PMOP in this population.
A retrospective observational study was conducted, enrolling 324 postmenopausal female patients with T2DM who were hospitalized at our hospital from September 2021 to November 2024. Participants were divided into an osteoporosis group (T-score ≤ − 2.5, n = 141) and a non-osteoporosis group (T-score > − 2.5, n = 183) based on lumbar spine bone mineral density (BMD) measured by dual-energy X-ray absorptiometry. Data on age, body mass index (BMI), BMD, serological indicators, and GNRI were collected and compared between the two groups. Correlation analysis was performed to examine the relationship between GNRI and various parameters. Binary logistic regression was used to identify independent factors influencing PMOP. The predictive efficacy of GNRI was assessed using the receiver operating characteristic (ROC) curve.
Compared to the non-osteoporosis group, patients in the osteoporosis group were significantly older and had significantly lower levels of GNRI, BMI, lumbar spine T-score, total protein, albumin, uric acid, albumin-corrected calcium, serum phosphorus, and 25-hydroxyvitamin D (all p
In postmenopausal female patients with T2DM, a higher GNRI value is independently associated with a lower risk of PMOP. GNRI demonstrates moderate discriminatory ability for identifying PMOP in this population and may serve as a simple and useful auxiliary indicator for assessing skeletal health risk in clinical practice, pending further prospective validation.